Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/25155

Title:	Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial.
Authors:	Robles, Nicolás Roberto Peces, Ramón Gómez-Ferrer, Álvaro Villacampa, Felipe Álvarez-Ossorio, Jose Luis Pérez-Segura, Pedro Morote, Juan Herrera-Imbroda, Bernardo Nieto, Javier Carballido, Joaquín Anido, Urbano Valero, Marian Meseguer, Cristina Torra, Roser View more
Keywords:	Angiomyolipoma Everolimus Safety Tuberous sclerosis complex View more
Issue Date:	26-Sep-2016
Citation:	Orphanet J Rare Dis.2016 Sep;(11)1:128
Abstract:	Renal angiomyolipomas (AML) are usual manifestations of tuberous sclerosis complex (TSC) that may cause aneurism-related haemorrhages and renal impairment. Everolimus has emerged as an alternative to surgery/embolization. We provide further insight into everolimus safety and efficacy for TSC-related AML.
PMID:	27669821
URI:	https://hdl.handle.net/20.500.12530/25155
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:

File	Description	Size	Format
PMC5037621.pdf		499.74 kB	Adobe PDF	View/Open